Loading…
Lobbying Spend
—
Filings
7
Firms Hired
1
Active Period
2018–2019
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
CREATES Act of 2017
2018 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2212
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
2018 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
Client expense: — · Firm income: $10,000
Matched citations: S. 974
CREATES Act of 2017
2018 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2212
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
2018 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
Client expense: — · Firm income: $10,000
Matched citations: S. 974
CREATES Act of 2017
2018 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2212
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
2018 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
Client expense: — · Firm income: $10,000
Matched citations: S. 974
FAST Generics Act of 2017
2018 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2051 - The FAST Generics Act; H.R. 2212 - CREATES Act of 2017; H.R. 749 - The Lower Drug Costs Through Competition Act; H.R. 2430 - FDA Reauthorization Act of 2017; border adjustability tax
Client expense: — · Firm income: —
Matched citations: H.R. 2051
FAST Generics Act of 2017
2018 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2051 - The FAST Generics Act; H.R. 2212 - CREATES Act of 2017; H.R. 749 - The Lower Drug Costs Through Competition Act; H.R. 2430 - FDA Reauthorization Act of 2017; border adjustability tax
Client expense: — · Firm income: —
Matched citations: H.R. 2051
CREATES Act of 2017
2018 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2051 - The FAST Generics Act; H.R. 2212 - CREATES Act of 2017; H.R. 749 - The Lower Drug Costs Through Competition Act; H.R. 2430 - FDA Reauthorization Act of 2017; border adjustability tax
Client expense: — · Firm income: —
Matched citations: H.R. 2212
CREATES Act of 2017
2018 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2051 - The FAST Generics Act; H.R. 2212 - CREATES Act of 2017; H.R. 749 - The Lower Drug Costs Through Competition Act; H.R. 2430 - FDA Reauthorization Act of 2017; border adjustability tax
Client expense: — · Firm income: —
Matched citations: H.R. 2212
FDA Reauthorization Act of 2017
2018 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2051 - The FAST Generics Act; H.R. 2212 - CREATES Act of 2017; H.R. 749 - The Lower Drug Costs Through Competition Act; H.R. 2430 - FDA Reauthorization Act of 2017; border adjustability tax
Client expense: — · Firm income: —
Matched citations: H.R. 2430
FDA Reauthorization Act of 2017
2018 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2051 - The FAST Generics Act; H.R. 2212 - CREATES Act of 2017; H.R. 749 - The Lower Drug Costs Through Competition Act; H.R. 2430 - FDA Reauthorization Act of 2017; border adjustability tax
Client expense: — · Firm income: —
Matched citations: H.R. 2430
Lower Drug Costs through Competition Act
2018 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2051 - The FAST Generics Act; H.R. 2212 - CREATES Act of 2017; H.R. 749 - The Lower Drug Costs Through Competition Act; H.R. 2430 - FDA Reauthorization Act of 2017; border adjustability tax
Client expense: — · Firm income: —
Matched citations: H.R. 749
Lower Drug Costs through Competition Act
2018 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2051 - The FAST Generics Act; H.R. 2212 - CREATES Act of 2017; H.R. 749 - The Lower Drug Costs Through Competition Act; H.R. 2430 - FDA Reauthorization Act of 2017; border adjustability tax
Client expense: — · Firm income: —
Matched citations: H.R. 749
Source: Senate LDA